Shivani named one of top 20 women leaders in biopharma R&D
Endpoints | Dec 2021
Shivani receives V Foundation Bob Bast Translational Research Grant for proposal with one of the highest ratings by the Scientific Advisory Committee
V Foundation | Nov 2021
Shivani receives CCSG New Investigator Award
Hutch News | July 2021
Shivani receives Lung Cancer Discovery Award from the American Lung Association
American Lung Association | July 2021
Researchers in biotech, academia and Big Pharma are offering puzzle pieces to crack CAR-T for solid tumors. Will they ever snap together?
Endpoints | May 2021
Science Snacks: Dr. Shivani Srivastava on CAR T-cell therapy
Fred Hutch | April 2021
Shivani receives 10X Visium Technology Exploratory Award
Hutch News | April 2021
Spotlight on Shivani Srivastava, Improving Cancer Immunotherapies
Hutch News | March 2021
Science Spotlight, Remodeling the tumor microenvironment for improved CAR T-cell therapy
Hutch News | February 2021
Dr. Shivani Srivastava joins Human Biology Division, Immunotherapy IRC
Hutch News | January 2021
Dr. Shivani Srivastava (’04) honored with the Distinguished Alumni Award for 2019
The Overlake School | January 2020
Logic-gated CAR-T cells safely target distant tumor cells
Hutch News | May 2019
Tinkering with T cells
Hutch News | May 2018